BRD4 is upregulated in diverse types of cancer, resulting in the induction of potent oncogenes such as MYC, c-MYB, ERG, and E2F1 (Fujisawa and Filippakopoulos, 2017; Liang et al., 2021). Here, MYC is linked to cancer.